In total, 56 (1.2%) sporadic ALS patients carry one or more ALS-associated variants within CAV1/CAV2 enhancers compared to 2 (0.1%) of controls (risk ratio = 12.0). The gene discussed is CAV1; the disease is amyotrophic lateral sclerosis.